2 completed, 1 enrolling by invitation, 1 recruiting, 1 terminated. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 2, Enrolling by invitation 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Behcet Syndrome: new trials by email Literature Review of Behcet Syndrome trials Research Report on Behcet Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) RAY121 - Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP) | Phase 1 | Enrolling by invitation | Chugai Pharmaceutical | 144 | 2024-12-09 | 2026-07-17 |
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) RAY121 - Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP) | Phase 1 | Recruiting | Chugai Pharmaceutical | 144 | 2024-08-19 | 2026-07-22 |
| Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study Intravitreal Infliximab - Behçet's Disease, Uveitis | Phase 1 / Phase 2 | Completed | Cairo University | 20 | 2013-01-01 | 2015-12-03 |
| Anakinra for Behcet s Disease Anakinra - Autoimmune Connective Tissue Disorder, Immune System Diseases | Phase 1 / Phase 2 | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 6 | 2011-09-01 | 2017-05-12 |
| A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease XOMA 052 - Muckle Wells Syndrome, Autoinflammatory | Phase 1 / Phase 2 | Withdrawn | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2010-08-27 | 2017-07-02 | |
| Stem Cell Transplantation in Ocular Lesions of Behcet's Disease Autologous Stem Cell Transplantation - Retinitis, Behcet's Syndrome | Phase 1 | Terminated | Tehran University of Medical Sciences | 5 | 2007-12-01 | 2015-11-10 |
Antiphospholipid Syndrome (2) · Dermatomyositis (2) · Pemphigoid, Bullous (2) · Purpura, Thrombocytopenic, Idiopathic (2) · Uveitis (2) · Cryopyrin-Associated Periodic Syndromes (1) · Immune System Diseases (1) · Papilledema (1) · Retinal Vasculitis (1) · Retinitis (1) · Stomatitis, Aphthous (1) · Uveitis, Posterior (1)
Cardiovascular Diseases (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Eye Diseases (6) · Genetic Diseases, Inborn (6) · Hereditary Autoinflammatory Diseases (6) · Mouth Diseases (6) · Panuveitis (6) · Skin Diseases (6) · Skin Diseases, Genetic (6) · Skin Diseases, Vascular (6) · Skin and Connective Tissue Diseases (6) · Stomatognathic Diseases (6) · Uveal Diseases (6) · Uveitis, Anterior (6) · Vascular Diseases (6)
Interleukin 1 Receptor Antagonist Protein (1) · gevokizumab (1)
Chugai Pharmaceutical (2) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2) · Cairo University (1) · Tehran University of Medical Sciences (1)
United States (3) · Australia (2) · Austria (2) · Bulgaria (2) · Canada (2) · Croatia (2) · Czechia (2) · France (2) · Germany (2) · Hungary (2) · Italy (2) · Japan (2) · Netherlands (2) · Norway (2) · Poland (2)
Behrouz Nikbin, MD (1) · Fereydoun Davatchi, MD (1) · Hormoz Shams, MD (1) · Mahmoud Soliman, MD PhD (1) · Peter C Grayson, M.D. (1)